Table 3.
P-value Between-groups ANOVA | P-value TN versus NR | P-value TN versus SVR | P-value TN versus healthy | P-value NR versus SVR | P-value NR versus healthy | P-value SVR versus control | |
---|---|---|---|---|---|---|---|
IL-2 | 0.28 | 0.08 | 0.33 | 0.84 | > 0.99 | 0.09 | 0.38 |
IL-4 | 0.0001* | 0.07 | < 0.0001* | 0.0002* | 0.0106* | 0.003* | 0.053 |
IL-10 | 0.006* | 0.2918 | 0.003* | 0.009* | 0.04* | 0.01* | 0.93 |
TNF-α | 0.0016* | 0.77 | 0.04* | 0.0069* | 0.0047* | 0.0009* | 0.0958 |
IFN-γ | 0.51 | 0.99 | 0.60 | 0.77 | 0.6 | 0.55 | 0.47 |
Significant difference.
IFN-γ, γ-interferon; IL, interleukin; NR, non-responders; SVR, sustained virologic response; TN, treatment naïve; TNF-α, tumor necrosis factor-α.